2,641–2,660 of 6,563Income metrics use the latest annual filing · balance metrics use the latest reported period
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
JACSJackson Acquisition Co II$317.5M37.3×$358.34KAI pending
RNGTRange Capital Acquisition Corp II$317.65M56.5×$0AI pending
ELTPElite Pharmaceuticals Inc$317.76M11.2×$148.87M+77.1%$44.87M$39.42M$1.36MAI pending
PPHCPublic Policy Holding Company, Inc.$319.09M$186.54M+24.7%-$39M$36.92M$42.15MAI pending
VNDAVanda Pharmaceuticals Inc.$319.24M$216.11M+8.7%-$220.47M$55.88MAI pending
POLEAndretti Acquisition Corp. II$319.59M41.8×$225.38KAI pending
NHPNational Healthcare Properties, Inc.$319.85M$342.28M-3.3%-$57.69M$245.7MAI pending
NNDMNano Dimension Ltd.$320.1M$102.44M+77.3%-$293.3M$349.11M$138KAI pending
IACQIrenic Acquisition Corp.$320.46M$1.02MAI pending
PMTRPerimeter Acquisition Corp. I$320.59M40.6×$400.31K$0AI pending
VACIViking Acquisition Corp I$320.79M115.3×$711.81KAI pending
XNETXunlei Ltd$321.25M$462.41M+42.5%$1.05B$157.02M$75.62MAI pending
MTCMmtec, Inc.$321.67M$807.5K-56.8%-$56.08M$6.51M$405.59KAI pending
ALDFAldel Financial II Inc.$321.68M47.6×$283.11KAI pending
CAESCantor Equity Partners VII, Inc.$321.69M$362.73KAI pending
NREFNexPoint Real Estate Finance, Inc.$321.92M7.3×$6.38M$771.2MAI pending
OBIOOrchestra BioMed Holdings, Inc.$322.16M$33.48M+1,169.2%-$52.7M$20.47M$15MAI pending
TBITrueBlue, Inc.$323.01M$1.62B+3.1%-$47.96M$23.25M$82.4MAI pending
HRZNHorizon Technology Finance Corp$323.1M14.7×$135.01M$402.44MAI pending
PRQRProQR Therapeutics N.V.$323.13M€15.91M-15.9%-€42.18M€92.41M€4.87MAI pending